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Introduction: Review of opioid prescriptions in a hospital provides valuable information to 
health care professionals which may contribute to proper pain management; opioid utilization 
studies may help uncover factors that can be improved for better prescribing. To evaluate the 
use of opioid analgesics in a university hospital, a review of opioids prescribed in hospitalized 
patients was developed.
Methods: Information was obtained from the pharmacy database and medical records. The 
study period was 1 month.
Results: Medical records of 1156 patients admitted in July 2009 were analyzed. The most widely 
prescribed opioid was tramadol; the preferred administration route was intravenous; the main 
indication was severe pain; and major prescribers were from surgical departments.
Discussion: Underutilization of potent opioids for acute and chronic pain seems to occur.
Conclusion: Most prescribers prefer weak opioids, given intravenously to treat acute and chronic 
pain, while some patients may benefit from the prescription of more potent opioids.
Keywords: drug utilization, pain, tramadol, morphine, hydromorphone, pethidine
Introduction
Despite having been used for many years, opioid analgesics remain essential in the 
control of severe pain. Hence, monitoring of opioid prescribing practices is a starting 
point for acquiring basic information regarding the treatment of pain. Several reports 
have indicated limited use of opioid analgesics in Colombia, but there has been a 
recent and important increase in the use of morphine nationwide, although supplies 
are insufficient and do not meet the national demand.1 At a hospital level, review of 
prescriptions for opioid analgesics provides both prescribers and administrators with 
consolidated information on the routine use of these medications, and helps to ensure 
the quality and safety of prescriptions.2,3
Detailed information about prescriptions is particularly important in relation to 
opioid analgesics, because of the stigma attached to this family of medicines. This is 
due to biased overestimation of side effects, leading to reluctance to prescribe opioids. 
The result is underutilization4,5 and unnecessary pain experience by patients.6–8
Currently, there is a trend toward greater opioid use due to increased attention paid 
to the treatment of acute, chronic, and cancer-related pain.9–11 Pain management can 
benefit the patient in different aspects. In cases of patients with acute postoperative 
pain treated with adequate analgesic schemes, improved outcomes have been found.12 
In patients with chronic pain, pain management can help maintain or improve quality 
of life.13,14
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However, numerous reports indicate inadequate treatment 
of acute, chronic, and cancer-related pain. The purpose of 
this present research was to describe the opioid utilization 
profile in a university hospital and provide information that 
can be used in the future to compare patterns of opioid use 
over time.
Materials and methods
A retrospective review of opioid prescription (morphine, 
hydromorphone, pethidine, fentanyl, oxycodone, methadone, 
codeine, hydrocodone, and tramadol) during July 2009 at 
a multidisciplinary 190-bed university hospital in Bogota, 
Colombia was performed. During the study period, the 
monthly average occupancy rate was 83.41%. Inpatients 
were seen in all major subspecialties. Data concerning the 
opioids prescribed (prescribing physician, type of opioid, 
route of administration, and doses) as well as the patients’ 
medical records, were obtained from the hospital pharmacy. 
Three researchers collected data on relevant clinical vari-
ables (age, gender, diagnosis, reason for visit, type of pain, 
and duration of painful symptoms) from electronic medical 
records. To ensure accuracy, data were double-checked and 
recorded using Microsoft Excel. All prescriptions for opioids 
administered to hospitalized patients during the study period 
were included.
The inclusion criteria were adult inpatients that had 
been prescribed opioids. The exclusion criteria were: 
hospitalized patients who did not receive opioids, outpa-
tients, and obstetric and pediatric patients. The institutional 
research ethics committee approved the study. It should 
be noted that treatment of pain in this hospital is an essen-
tial factor for accreditation by the Joint Commission on 
Accreditation.
Statistical analyses
For quantitative variables, means and standard deviations 
(SDs) were calculated. When variables were asymmetri-
cally distributed, the median was calculated. Qualitative 
variables were expressed as absolute and relative percentage 
frequencies. The nonparametric Kruskal–Wallis test was 
used when appropriate. Bivariate analyses were performed to 
identify variables associated with the daily dose prescribed. 
All analyses were two-sided, and the alpha level was 0.05.
Results
The medical records of 1156 patients were reviewed; 
705 (60.99%) were female and 451 (39.01%) were male. The 
mean age was 48.11 years (range, 18–99 years).
Patients were divided into four age groups. The group 
aged under 44 years was the largest (n = 545, 47.15%), 
followed by the group comprising patients over 65 years of 
age (n = 257, 22.23%), those between 45 and 54 years, and 
those between 55 and 64 years (n = 159, 13.75%). Most of 
the opioid analgesics were prescribed in the emergency unit 
(n = 580, 50.17%).
The majority of patients could be grouped into four diag-
nostic categories based on the pain source: musculoskeletal 
system, gastrointestinal system, wounds and injuries, and 
urogenital system (n = 631, 54.58%) (Table 1). Most patients 
were treated for acute pain (n = 1010, 87.37%). Treatment of 
chronic pain and cancer pain was performed in 89 (7.70%) 
and 49 (4.24%) patients, respectively. Type of pain was 
unknown in eight patients due to missing data.
Tramadol
The most widely prescribed opioid analgesic was tramadol, 
prescribed to 606 patients (52.42%) (Table 2); 305 (50.33%) 
were under 44 years, and 113 (18.65%) were over 65 years.
Tramadol was the most widely prescribed opioid for 
acute pain (n = 528, 52.28%). Tramadol was also the most 
frequently used analgesic for chronic pain, with 64 patients 
(71.91%) being prescribed this medication; 10 (20.41%) out 
of 49 cancer pain patients were prescribed tramadol.
Tramadol was most frequently administered intrave-
nously (73.80%). The starting intravenous dose for tramadol 
was 50 mg (SD 6.09) by emergency unit prescribers, 70 mg 
(SD 56.62) by pain service prescribers, 45 mg (SD 11.03) by 
inpatient medical services prescribers, and 120 mg (SD 14.49) 
Table 1 Distribution of patients according to diagnosis
Diagnosis n %
Musculoskeletal system 202 17.47
gastrointestinal system 167 14.45
Wounds and injuries 157 13.58
Urogenital system 105 9.08
Headache disorders 95 8.22
Other 87 7.53
Obstetric surgical procedures 84 7.27
Cardiovascular system 52 4.50
Malignant neoplasms 42 3.63
Benign neoplasms 42 3.63
Respiratory system 37 3.20
Infection 35 3.03
Peripheral nervous system diseases 18 1.56
Endocrine system 11 0.95
Skin 10 0.87
Eye 8 0.69
Congenital 4 0.35
Total 1156 100
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by inpatient surgical services prescribers (Table 3). Tramadol 
was the preferred opioid analgesic among emergency unit 
prescribers (Figure 1).
Morphine
Morphine was the second most prescribed medication 
(n = 274, 23.70%) (Table 2). The most frequent indication for 
its prescription was acute pain (88.64%). Of the 274 patients 
prescribed morphine, the largest number was given the drug 
by emergency unit prescribers (n = 141, 51.46%), followed 
by inpatient surgical services prescribers (n = 53, 20.87%), 
then pain service prescribers (n = 48, 17.52%) and inpatient 
medical services (n = 32, 11.68%). Differences were found 
for morphine with regard to the type of pain endured by the 
patient and the daily dose prescribed. The daily dose for 
chronic pain patients was 5.68 mg (SD 2.95), compared with 
8.96 mg (SD 11.08) for patients with acute pain and 24.06 mg 
(SD 39.86) for cancer pain patients (P = 0.017, nonparametric 
Kruskal–Wallis test) (Table 3). For patients with cancer 
pain, morphine was the most frequently prescribed analgesic 
(n = 18, 36.73%) (Figure 2). Most doses of morphine were 
administered intravenously (98.60%).
Hydromorphone
The most frequent indication for prescription of hydro-
morphone was acute pain (80.65%). The daily dose of 
hydromorphone given to acute pain patients (3.77 mg, SD 
11.75) was similar to the dose given to patients with chronic 
pain (3.45 mg, SD 2.32) and cancer pain (4.86 mg, SD 
6.95) (P = 0.067, nonparametric Kruskal–Wallis test) 
(Table 3). Approximately one-third of cancer pain patients 
were prescribed hydromorphone (n = 16, 32.65%). Of the 
hydromorphone prescriptions, 99.20% were administered 
intravenously.
Pethidine
Pethidine was prescribed to 103 (8.91%) of the 1156 patients 
studied. The most frequent indication was acute pain 
(92.23%). The largest group of prescribers was surgical 
inpatient services physicians, with 49 patients (47.57%) 
prescribed pethidine. About half of the patients prescribed 
pethidine (n = 52, 50.49%) were less than 44 years old, and 
21 (20.39%) were over 65.
The daily dose of pethidine given to cancer related pain 
patients was 52.32 mg (SD 38.88). Of the pethidine prescrip-
tions, 100% were administered intravenously.
Fentanyl
Twelve fentanyl prescriptions were issued. The most frequent 
indication for its use was acute pain (n = 9, 75.00%). The 
mean initial dose was 96.67 µg. Most doses were adminis-
tered intravenously (83.33%). No patches were prescribed 
during the study period, and no cancer pain patients were 
prescribed fentanyl.
Other opioid analgesics
With respect to the other opioid analgesics, four (codeine, 
methadone, oxycodone, and hydrocodone) were prescribed 
to a small number of patients (n = 14, 1.21%). All of them 
were taken orally.
Prescribers profile 
Overall, the prescription of potent opioid agonists (morphine, 
hydromorphone, and fentanyl) was different for each group 
Table 2 Distribution of prescribed opioid analgesics
Opioid analgesic n %
Tramadol 606 52.42
Morphine 274 23.7
Hydromorphone 147 12.72
Pethidine 103 8.91
Fentanyl 12 1.04
Codeine 10 0.87
Methadone 2 0.17
Oxycodone 1 0.09
Hydrocodone 1 0.09
Total 1156 100
Table 3 Daily doses (milligrams) according to type of pain
Chronic pain Acute pain Cancer P Valuea
Median Mean (SD) Median Mean (SD) Median Mean (SD)
Morphine 4.00 5.68 (2.95) 3.00 8.96 (11.08) 11.33 24.06 (39.86) 0.017
Pethidine 30.00 31.00 (6.63) 50.00 56.14 (38.90) 54.64 52.32 (38.88) 0.33
Hydromorphone 2.81 3.45 (2.32) 1.55 3.77 (11.75) 2.12 4.86 (6.95) 0.067
Fentanyl 1.20 1.60 (1.83) 0.19 1.31 (1.70) – – –
Tramadol 50.00 59.32 (38.35) 50.00 65.00 (42.52) 35.00 65.68 (72.79)  0.169
Note: aNonparametric Kruskal–Wallis.
Abbreviation: SD, standard deviation.
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of prescribers. The pain service prescribers utilized this group 
of potent analgesics the most; of a total of 103 patients given 
prescriptions by the pain service prescribers, these medica-
tions were given to 93 (90.29%). In the surgical inpatient 
service (n = 301), 127 patients (42.19%) were prescribed 
these drugs; in the medical inpatient service (n = 168), 
55 patients (32.74%) were prescribed potent opioids; of the 
emergency unit patients (n = 580), 156 patients (26.90%) 
were prescribed these medicines.
Approximately one-third of the patients (n = 404, 
34.95%) were prescribed acetaminophen, whereas other 
nonsteroidal anti-inflammatory drugs were prescribed to 
23.70% of patients (n = 274).
Discussion
The analysis of the treatment of pain using opioid analgesics 
in 1156 patients admitted to a university hospital in Colombia 
shows that tramadol was the most frequently prescribed 
medication for acute and chronic pain, while morphine was 
most often prescribed for cancer-related pain.
Several factors may explain the popularity of tramadol. 
First, the results indicate the knowledge of the prescribers 
regarding tramadol’s effectiveness. Indeed, its efficacy in 
acute postoperative pain control has been demonstrated fol-
lowing intravenous administration.15 When compared with 
morphine in the treatment of acute musculoskeletal pain, 
tramadol has similar efficacy and is an alternative treatment.16 
The findings of this present study are consistent with the wide 
variability in opioid analgesic requirements observed among 
individuals treated for pain. In relation to its efficacy for 
chronic pain, a systematic review on chronic low back pain 
showed that tramadol was more effective than placebo in pain 
relief assessed after 4 weeks of treatment,17 with a frequency 
of adverse events similar to that of  placebo. In short, if one 
considers only analgesic efficacy, tramadol prescriptions 
would be well indicated in patients with acute and chronic 
pain. The preference for tramadol can also be explained by 
the lower incidence of respiratory depression18 as compared 
with other opioid agonists, a fact that generates greater con-
fidence in the prescriber; it has been acknowledged that fear 
of respiratory depression is a barrier for morphine prescrip-
tion. The number of prescriptions may also be explained by 
the fact that tramadol is not subject to any “special control” 
by the Ministry of Health because it is an over-the-counter 
opioid analgesic in Colombia, unlike the other potent opioid 
analgesics evaluated (morphine, methadone, hydromorphone, 
pethidine, fentanyl), which are strictly regulated. This govern-
ment regulation requires doctors to complete special forms 
and mandates a review of prescriptions by authorities, which 
hinders the medical use of opioid analgesics.19 In addition, 
tramadol is marketed by private pharmaceutical companies, 
whereas the other opioids are distributed noncommercially 
by the Ministry of Health. This situation favors tramadol use 
since commercial interests in the consumption of tramadol 
only have to compete with a very limited state interest regard-
ing the availability of opioids in Colombia.20 Finally, cancer 
pain studies have also demonstrated tramadol’s efficacy to 
curb moderate pain.21 However, reports of adverse effects may 
lead to the increased use of other opioid agonists that cause 
fewer serious pharmacological reactions than tramadol.22
The factors underlying the morphine prescription results 
detailed in this study include morphine’s well established 
efficacy in moderate to severe pain23,24 and the fact that 
morphine is the opioid analgesic that has been used for the 
longest period of time at the hospital where the research was 
conducted. On the other hand, the comparatively lower num-
ber of morphine prescriptions in comparison to tramadol may 
be due to a limitation in the knowledge required to prescribe 
it, or an opioid-phobic attitude of doctors and paramedical 
staff, which has been documented for opioids for acute pain.25 
A notable finding in the treatment of pain in cancer patients 
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is the preference for powerful opioid agonists, as proven 
by the fact that most prescriptions in this group were for 
morphine and hydromorphone (Figure 2). Another interest-
ing finding from the acute pain group is the low number of 
prescriptions for oral painkillers, a result that contrasts those 
of a previous study,26 showing that up to 57.0% of patients 
who took an oral opioid did so to control acute pain. Apart 
from the natural comfort offered by oral administration, it 
is recognized to be effective in controlling acute pain after 
analgesic titration and when gastrointestinal function has 
recovered. The marked preference for intravenous adminis-
tration (98.60%) could represent a lack of knowledge of the 
advantages of oral administration.
The third most commonly used opioid was hydromor-
phone (12.72%). Its mechanism of action and safety profile 
are similar to those of morphine. However, it is less well 
known than morphine and pethidine in this study’s setting, 
having been available to prescribers for a shorter period of 
time. In fact, this medicine is not available in many regions 
of the country. It was administered intravenously in 99.20% 
of the cases. The most frequent indication for its prescription 
was acute pain (80.65%).
For pethidine (8.91% of all prescriptions), the most 
frequent indication was acute pain (92.23%). Currently, 
this medicine is less frequently prescribed due to its lower 
analgesic power and its potential for neurotoxicity in patients 
with impaired renal excretion.27 This low percentage of pre-
scriptions may represent the evolution of prescribers toward 
better treatment options.
Fentanyl, hydrocodone, oxycodone, codeine, and metha-
done were prescribed to very few patients (less than 2%). At 
the hospital where the study was conducted, fentanyl is used 
almost exclusively in operating rooms and intensive care 
units, a fact that explains the small number of prescriptions. 
 However, the low number of transdermal fentanyl prescrip-
tions is notable, and no cancer pain patient received fentanyl 
patches. One possible explanation is the limited number of 
cancer pain patients in the study sample. Another possible 
impediment is the clinical skill needed for fentanyl patch 
prescription. The other three drugs are commonly given 
orally, which is reflected in their very limited use in this 
hospital setting.
The low number of prescribed oral analgesics could be 
due to the absence of a postoperative home-based analge-
sia program. The great majority of opioid-treated patients 
were medicated intravenously, possibly because of hospital 
tradition or the underestimation of the effectiveness of other 
routes of administration.
This review of the use of opioid analgesics reveals the 
profile of use of these medicines and can help to identify 
areas of possible improvement in prescription. Since the type 
of prescription forms a part of an effective treatment plan 
for pain, these studies can help to improve analgesia in the 
hospital. These studies are especially useful in settings with 
limited resources to improve pain control.
Due to incomplete records, detailed analysis of the use 
of nonopioid analgesics was not possible. However, it was 
possible to establish that paracetamol was the analgesic most 
commonly co-administered with opioid analgesics.
As previously mentioned, a limitation in interpreting 
these results is that scores for pain intensity (possibly the 
variable of greatest interest to patients) were not included, 
and side effects were not recorded. Consequently, analysis 
of analgesic use partially depended on the dose received, 
which did not allow us to evaluate the result of the use of 
specific medications in an integral fashion. Thus, this present 
study could be a pilot to direct future research to support 
prescribers in practice. Nevertheless, the data provide useful 
information that will assist health care professionals working 
in similar hospitals, such as those in developing countries. In 
fact, after the completion of this study, the hospital began to 
record pain intensity in all hospitalized patients and began 
efforts to avoid duplication of analgesic treatments.
Conclusion
Opioids were most commonly prescribed for acute pain. 
Overall, prescribers in the hospital studied preferred tramadol 
to treat acute and chronic pain; however, morphine was the 
preferred opioid for cancer pain. Pain service prescribers pre-
ferred potent opioid agonists for the treatment of all types of 
pain. Monitoring of opioid prescriptions is recommended as 
a useful tool that provides clinicians relevant and meaningful 
feedback to determine optimal treatments for patients.
Disclosure
The authors report no conflicts of interest in this work.
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